Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants
Vanessa Monteil, Brett Eaton, Elena Postnikova, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 8
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Gavin Y. Oudit, Kaiming Wang, Anissa Viveiros, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 906-922
Open Access | Times Cited: 74
Advances in developing ACE2 derivatives against SARS-CoV-2
Haoran Zhang, Panjing Lv, Jingrui Jiang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e369-e378
Open Access | Times Cited: 38
Crimean–Congo haemorrhagic fever virus uses LDLR to bind and enter host cells
Vanessa Monteil, Shane C. Wright, Matheus Dyczynski, et al.
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1499-1512
Open Access | Times Cited: 9
Rapid Generation of Circulating and Mucosal Decoy Human ACE2 using mRNA Nanotherapeutics for the Potential Treatment of SARS‐CoV‐2
Jeonghwan Kim, Antony Jozić, Anindit Mukherjee, et al.
Advanced Science (2022) Vol. 9, Iss. 35
Open Access | Times Cited: 36
Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation
Anthony J. Turner, Natalia N. Nalivaeva
Peptides (2022) Vol. 151, pp. 170766-170766
Open Access | Times Cited: 31
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
Robert H. Shoemaker, Reynold A. Panettieri, Steven K. Libutti, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0271066-e0271066
Open Access | Times Cited: 27
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 4
Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
Lingbing Zhang, Yandan Zhang, Xia Qin, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 18
SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
Mariana Valério, Luís Borges-Araújo, Manuel N. Melo, et al.
Frontiers in Medical Technology (2022) Vol. 4
Open Access | Times Cited: 15
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic
Hongyin Chen, Jiangyun Peng, Tengyao Wang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115370-115370
Open Access | Times Cited: 14
Angiotensin-(1–9) in hypertension
Ignacio Norambuena‐Soto, Camila López‐Crisosto, Javiera Martinez-Bilbao, et al.
Biochemical Pharmacology (2022) Vol. 203, pp. 115183-115183
Closed Access | Times Cited: 11
In planta deglycosylation improves the SARS-CoV-2 neutralization activity of recombinant ACE2-Fc
Shiva Izadi, Ulrike Vavra, Stanislav Melnik, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 6
Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor
Gokulnath Mahalingam, Porkizhi Arjunan, Yogapriya Periyasami, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells
Flavia Trionfetti, Tonino Alonzi, Giulio Bontempi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
The 14th International Podocyte Conference 2023: from podocyte biology to glomerular medicine
Sybille Koehler, Felicitas E. Hengel, Bernhard Dumoulin, et al.
Kidney International (2024) Vol. 105, Iss. 5, pp. 935-952
Open Access | Times Cited: 1
A Piecewise Design Approach to Engineering a Miniature ACE2 Mimic to Bind SARS-CoV-2
Yashavantha L. Vishweshwaraiah, Brianna Hnath, Jian Wang, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 5, pp. 3238-3246
Closed Access | Times Cited: 1
Facilitating and restraining virus infection using cell-attachable soluble viral receptors
Heng Zhang, Zhengli Wang, Huong T. T. Nguyen, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 45
Open Access | Times Cited: 1
Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps
Soumya G. Remesh, Gregory E. Merz, Axel F. Brilot, et al.
Structure (2023) Vol. 31, Iss. 3, pp. 253-264.e6
Open Access | Times Cited: 4
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection
Arianna Romani, Domenico Sergi, Enrico Zauli, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 4
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19
Rohan Ameratunga, Emily Mears, Euphemia Leung, et al.
Clinical & Experimental Immunology (2023) Vol. 214, Iss. 3, pp. 289-295
Closed Access | Times Cited: 4
Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19
Stephani C. Wang, Fengmin Zhang, Hui Zhu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 7
Serum ACE2 Level is Associated With Severe SARS-CoV-2 Infection: A Cross-Sectional Observational Study
Amjad Bani Hani, Nafez Abu Tarboush, Mo’ath Bani Ali, et al.
Biomarker Insights (2022) Vol. 17
Open Access | Times Cited: 6
SARS-CoV-2 spike interactions with the renin-angiotensin-aldosterone system -Consequences of adverse reactions of vaccination-
K Lehmann
(2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top